Latest News
RBS Invoice Finance (RBSIF) has appointed Piers Harmer and Jon Hughes to the London-based RBSIF corporate team.
Both are experienced in the invoice finance and asset based lending industries and join the bank as business development directors.
They are new to RBSIF with Harmer joining from Lloyds TSB Commercial Finance and Hughes from GE Commercial Finance.
Harmer has national responsibility for financial sponsor coverage and will work closely with private equity houses to demonstrate the benefits of using ABL to support their transactions.
Hughes worked for GE Commercial Finance for 10 years as well as NMB Heller and UCB
Japan is a market that James Sullivan, manager of the CF Miton Arcturus Fund, continues to believe is the most realistically valued of all the major equity markets…
The level of the exchange rate is generally viewed as crucial to the prospects for the Japanese economy, therefore the domestic stock market in Japan tends to outperform when the domestic currency weakens against the dollar. This was clearly evident in Q1 when Japanese equities comfortably outperformed US equities, buoyed by a significant depreciation of the yen against the dollar. However, the outperformance has reversed in recent weeks as the yen has
The Cambridge Associates Australia Private Equity and Venture Capital Index rose by 7.80 per cent (net of fees) in the 12 months to 31 March 2012, according to the latest quarterly report released by The Australian Private Equity and Venture Capital Association.
The C|A Australia Index outperformed the S&P/ASX 300 Accumulation Index by 14.07 per cent over the same period.
For the quarter ending 31 March 2012, the C|A Australia Index rose by 1.43 per cent, marking the fifth consecutive quarter of positive returns. Nine of the last ten quarters have now had positive returns, the sole exception being Q4
HarbourVest Global Private Equity’s estimated net asset value per share is USD11.31 at the end of July 2012, a USD0.18 per share decrease (1.6 per cent) from 30 June 2012 (USD11.49).
This change mainly reflects decreases in the value of privately-held investments as a portion of the portfolio was re-valued to reflect 30 June 2012 valuations, decreases in the value of publicly-traded securities, and foreign currency movement.
At 31 July 2012, HVPE is valuing the Absolute portfolio at USD24.77 per share (including dividends received since closing), which is unchanged from 30 June 2012 and a 34 per cent increase
HighWater, a boutique corporate governance services firm based in the Cayman Islands, has expanded with a New York-based principal.
Matt Auriemma, who will be based in New York, joins as a principal of HighWater, providing independent director services to investment funds, mostly hedge funds and other alternative investment vehicles.
“HighWater has an impeccable reputation for corporate governance in the industry and an impressive client portfolio including many of the world’s top alternative investment managers” says Auriemma. “My experience complements that of the team and I am looking forward to contributing to the future growth of this impressive firm.”
Auriemma was
Medical Marijuana has signed closing documentation for a USD2m line of credit with Lotus Capital, a Chicago based private equity firm.
The line of credit will be used as a reserve fund for product expansion of the Dixie X line of Cannabidoil (CBD) based products as well as to support the national marketing campaign of the Dixie X and CanChew gum product launch, scheduled for early September.
The line of credit will also be available to support future expansion through company acquisitions.
This new revolving line of credit will be secured against shares of the company’s capital stock. MJNA is
Catalyst Investors has held the final closing of the firm’s third fund, Catalyst Investors III, with total commitments of USD213m – the firm’s largest fund to date.
Consistent with its strategy in recent funds, Catalyst expects to continue investing in high-growth, lower middle-market cloud computing, wireless infrastructure and digital media companies.
“Catalyst’s cohesive team, proven track record, cogent strategy and commitment to transparency enabled us to attract a number of highly-regarded institutional investors new to our firm,” says Gene Wolfson, partner with Catalyst Investors and head of the firm’s investor relations and business development.
New investors in Fund III include
It is quite a consensus call to have an overweight position on developed market credit but, says Williams Sels (pictured), UK Head of Investment Strategy at HSBC Private Bank, this still makes a lot of sense…
We would rather be lending to non-financial corporates than to most governments. And with global economic growth probably below a normal pace and very difficult to estimate, we think it is still too courageous to upgrade equities or commodities. High corporate bond issuance activity should thus continue to be matched by strong investor demand, in our view.
1. Fundamentals: positive but unexciting global
Fundraising by private equity funds focused on the emerging markets held steady in the first two quarters and maintained a 15 per cent share of the global fundraising total, according to the Emerging markets Private Equity Association (EMPEA).
With USD17.2bn raised in the first six months of 2012, or nearly half of the USD38.5bn raised in all of 2011, emerging market funds are on track to match 2011 levels.
During the same period, investment activity cooled slightly, with decreases in the number of deals in China and India offset by an uptick in deals in the Middle East, Africa,
Symphony International’s net asset value as at 30 June 2012 was USD1.2414 per share, a 10.46 per cent increase from USD1.1239 on 31 December 2011, according to the company’s interim results.
Increased deal activity resulted in the completion of several new transactions in early 2012.
In February 2012, Symphony invested in Integrated Healthcare Hastaneler Turkey (IHT), which is the controlling shareholder of Acibadem Saglik Yatirimlari Holding (ASYH), one of the largest healthcare groups in Turkey. At the time of the transaction, Symphony agreed to convert its investment into a minority interest in IHT’s parent, IHH Healthcare Berhad (IHH), at
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
